Cargando…

Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization

Biological subtypes in Alzheimer’s disease, originally identified on neuropathological data, have been translated to in vivo biomarkers such as structural magnetic resonance imaging and positron emission tomography, to disentangle the heterogeneity within Alzheimer’s disease. Although there is metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Rosaleena, Mårtensson, Gustav, Poulakis, Konstantinos, Muehlboeck, J-Sebastian, Rodriguez-Vieitez, Elena, Chiotis, Konstantinos, Grothe, Michel J, Nordberg, Agneta, Ferreira, Daniel, Westman, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713995/
https://www.ncbi.nlm.nih.gov/pubmed/33305264
http://dx.doi.org/10.1093/braincomms/fcaa192
_version_ 1783618660947984384
author Mohanty, Rosaleena
Mårtensson, Gustav
Poulakis, Konstantinos
Muehlboeck, J-Sebastian
Rodriguez-Vieitez, Elena
Chiotis, Konstantinos
Grothe, Michel J
Nordberg, Agneta
Ferreira, Daniel
Westman, Eric
author_facet Mohanty, Rosaleena
Mårtensson, Gustav
Poulakis, Konstantinos
Muehlboeck, J-Sebastian
Rodriguez-Vieitez, Elena
Chiotis, Konstantinos
Grothe, Michel J
Nordberg, Agneta
Ferreira, Daniel
Westman, Eric
author_sort Mohanty, Rosaleena
collection PubMed
description Biological subtypes in Alzheimer’s disease, originally identified on neuropathological data, have been translated to in vivo biomarkers such as structural magnetic resonance imaging and positron emission tomography, to disentangle the heterogeneity within Alzheimer’s disease. Although there is methodological variability across studies, comparable characteristics of subtypes are reported at the group level. In this study, we investigated whether group-level similarities translate to individual-level agreement across subtyping methods, in a head-to-head context. We compared five previously published subtyping methods. Firstly, we validated the subtyping methods in 89 amyloid-beta positive Alzheimer’s disease dementia patients (reference group: 70 amyloid-beta negative healthy individuals) using structural magnetic resonance imaging. Secondly, we extended and applied the subtyping methods to 53 amyloid-beta positive prodromal Alzheimer’s disease and 30 amyloid-beta positive Alzheimer’s disease dementia patients (reference group: 200 amyloid-beta negative healthy individuals) using structural magnetic resonance imaging and tau positron emission tomography. Subtyping methods were implemented as outlined in each original study. Group-level and individual-level comparisons across methods were performed. Each individual subtyping method was replicated, and the proof-of-concept was established. At the group level, all methods captured subtypes with similar patterns of demographic and clinical characteristics, and with similar cortical thinning and tau positron emission tomography uptake patterns. However, at the individual level, large disagreements were found in subtype assignments. Although characteristics of subtypes are comparable at the group level, there is a large disagreement at the individual level across subtyping methods. Therefore, there is an urgent need for consensus and harmonization across subtyping methods. We call for the establishment of an open benchmarking framework to overcome this problem.
format Online
Article
Text
id pubmed-7713995
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77139952020-12-09 Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization Mohanty, Rosaleena Mårtensson, Gustav Poulakis, Konstantinos Muehlboeck, J-Sebastian Rodriguez-Vieitez, Elena Chiotis, Konstantinos Grothe, Michel J Nordberg, Agneta Ferreira, Daniel Westman, Eric Brain Commun Original Article Biological subtypes in Alzheimer’s disease, originally identified on neuropathological data, have been translated to in vivo biomarkers such as structural magnetic resonance imaging and positron emission tomography, to disentangle the heterogeneity within Alzheimer’s disease. Although there is methodological variability across studies, comparable characteristics of subtypes are reported at the group level. In this study, we investigated whether group-level similarities translate to individual-level agreement across subtyping methods, in a head-to-head context. We compared five previously published subtyping methods. Firstly, we validated the subtyping methods in 89 amyloid-beta positive Alzheimer’s disease dementia patients (reference group: 70 amyloid-beta negative healthy individuals) using structural magnetic resonance imaging. Secondly, we extended and applied the subtyping methods to 53 amyloid-beta positive prodromal Alzheimer’s disease and 30 amyloid-beta positive Alzheimer’s disease dementia patients (reference group: 200 amyloid-beta negative healthy individuals) using structural magnetic resonance imaging and tau positron emission tomography. Subtyping methods were implemented as outlined in each original study. Group-level and individual-level comparisons across methods were performed. Each individual subtyping method was replicated, and the proof-of-concept was established. At the group level, all methods captured subtypes with similar patterns of demographic and clinical characteristics, and with similar cortical thinning and tau positron emission tomography uptake patterns. However, at the individual level, large disagreements were found in subtype assignments. Although characteristics of subtypes are comparable at the group level, there is a large disagreement at the individual level across subtyping methods. Therefore, there is an urgent need for consensus and harmonization across subtyping methods. We call for the establishment of an open benchmarking framework to overcome this problem. Oxford University Press 2020-11-09 /pmc/articles/PMC7713995/ /pubmed/33305264 http://dx.doi.org/10.1093/braincomms/fcaa192 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Mohanty, Rosaleena
Mårtensson, Gustav
Poulakis, Konstantinos
Muehlboeck, J-Sebastian
Rodriguez-Vieitez, Elena
Chiotis, Konstantinos
Grothe, Michel J
Nordberg, Agneta
Ferreira, Daniel
Westman, Eric
Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title_full Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title_fullStr Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title_full_unstemmed Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title_short Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization
title_sort comparison of subtyping methods for neuroimaging studies in alzheimer’s disease: a call for harmonization
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713995/
https://www.ncbi.nlm.nih.gov/pubmed/33305264
http://dx.doi.org/10.1093/braincomms/fcaa192
work_keys_str_mv AT mohantyrosaleena comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT martenssongustav comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT poulakiskonstantinos comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT muehlboeckjsebastian comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT rodriguezvieitezelena comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT chiotiskonstantinos comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT grothemichelj comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT nordbergagneta comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT ferreiradaniel comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization
AT westmaneric comparisonofsubtypingmethodsforneuroimagingstudiesinalzheimersdiseaseacallforharmonization